BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25943864)

  • 1. Conservative Treatment Seems the Best Choice in Adenocarcinoma In Situ of the Cervix Uteri.
    Baalbergen A; Molijn AC; Quint WG; Smedts F; Helmerhorst TJ
    J Low Genit Tract Dis; 2015 Jul; 19(3):239-43. PubMed ID: 25943864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.
    Latif NA; Neubauer NL; Helenowski IB; Lurain JR
    J Low Genit Tract Dis; 2015 Apr; 19(2):97-102. PubMed ID: 25089550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.
    Cohen PA; Brand A; Sykes P; Wrede DCH; McNally O; Eva L; Rao A; Campion M; Stockler M; Powell A; Codde J; Bulsara MK; Anderson L; Leung Y; Farrell L; Stoyles P
    BMJ Open; 2017 Aug; 7(8):e017576. PubMed ID: 28851799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.
    Kim JH; Park JY; Kim DY; Kim YM; Kim YT; Nam JH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):100-3. PubMed ID: 19428171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix.
    Srisomboon S; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):377-382. PubMed ID: 30803195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy.
    Cohen PA; Leung Y; Anderson L; van der Griend R; Chivers P; Bilic S; Bittinger S; Brand A; Bulsara MK; Codde J; Eva L; Farrell L; Harker D; Herbst U; Jeffares S; Loh D; McNally O; Mohan GR; Nicholson T; Powell A; Salfinger SG; Simcock B; Stewart C; Silvers J; Stockler MR; Sykes P; Stoyles P; Tan A; Tan AL; Wrede CDH
    Gynecol Oncol; 2020 Dec; 159(3):623-629. PubMed ID: 33032824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?
    Munro A; Leung Y; Spilsbury K; Stewart CJ; Semmens J; Codde J; Williams V; O'Leary P; Steel N; Cohen P
    Gynecol Oncol; 2015 May; 137(2):258-63. PubMed ID: 25769659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study.
    Tan JHJ; Malloy MJ; Thangamani R; Gertig D; Drennan KT; Wrede CD; Saville M; Quinn M
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):123-129. PubMed ID: 31578727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up Findings in Postconservative Treatment Surveillance for Women With Cervical Adenocarcinoma In Situ.
    Upadhyay Baskota S; Wang T; Zhao C
    J Low Genit Tract Dis; 2021 Jan; 25(1):38-42. PubMed ID: 33284146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
    Jiang Y; Chen C; Li L
    PLoS One; 2017; 12(1):e0170587. PubMed ID: 28125627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.
    Taylor JS; Panico V; Caputo T; Gerber D; Gupta D; Pirog E; Holcomb K
    Eur J Gynaecol Oncol; 2014; 35(6):641-5. PubMed ID: 25556268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
    Dedecker F; Graesslin O; Bonneau S; Quéreux C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of combined high-grade squamous intraepithelial lesion and adenocarcinoma in situ of the uterine cervix: human papillomavirus genotype and methylation status and immunohistochemical study.
    Kawakami F; Semba S; Itami H; Oka N; Sudo T; Ebina Y; Ohbayashi C; Mikami Y; Yokozaki H; Itoh T
    Kobe J Med Sci; 2014 Nov; 60(3):E66-73. PubMed ID: 25612672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
    Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
    Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.